Both guidances will assist stakeholders with post-approval study requirements and postmarket surveillance plans as well as the FDA policy of publishing data.
Read more: FDA In Brief: FDA Announces Draft Guidances to Help Increase Transparency, Assist Reporting and Timely Completion for Certain Medical Device Studies after FDA Approval or Clearance